| Dr Jay Howard Woodland, MD | |
|
520 Mary St Ste 520, Evansville, IN 47710-1682 | |
| (812) 424-8231 | |
| (812) 435-8794 |
| Full Name | Dr Jay Howard Woodland |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 520 Mary St Ste 520, Evansville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689872970 | NPI | - | NPPES |
| 201105430 | Medicaid | IN | |
| 036118354 | Medicaid | IL | |
| 7100208120 | Medicaid | KY | |
| 000000774263 | Other | IN | ANTHEM |
| 01070738 | Other | IN | INDIANA STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 01070738A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Deaconess Hospital Inc | Evansville, IN | Hospital |
| Ascension St Vincent Evansville | Evansville, IN | Hospital |
| Memorial Hospital And Health Care Center | Jasper, IN | Hospital |
| Gibson General Hospital | Princeton, IN | Hospital |
| Methodist Hospital | Henderson, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Evansville Surgical Associates Inc | 1557346723 | 39 |
News Archive
Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
Scientists at the University of North Carolina at Chapel Hill have demonstrated that normal development of the eye requires the right amount of a neural stem cell gene be expressed at the right time and place.
The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide. Past research has suggested that ecstasy users perform worse than nonusers on some tests of mental ability. But there are concerns that the methods used to conduct that research were flawed, and the experiments overstated the cognitive differences between ecstasy users and nonusers.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
Thirty-five countries now face serious food shortages, including two dozen in Africa, according to a report released by the United Nations Food and Agricultural Organization (FAO).
› Verified 3 days ago
| Entity Name | Evansville Surgical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497707517 PECOS PAC ID: 1557346723 Enrollment ID: O20040622000449 |
News Archive
Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
Scientists at the University of North Carolina at Chapel Hill have demonstrated that normal development of the eye requires the right amount of a neural stem cell gene be expressed at the right time and place.
The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide. Past research has suggested that ecstasy users perform worse than nonusers on some tests of mental ability. But there are concerns that the methods used to conduct that research were flawed, and the experiments overstated the cognitive differences between ecstasy users and nonusers.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
Thirty-five countries now face serious food shortages, including two dozen in Africa, according to a report released by the United Nations Food and Agricultural Organization (FAO).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jay Howard Woodland, MD 520 Mary St, Suite 520, Evansville, IN 47710-1682 Ph: (812) 424-8231 | Dr Jay Howard Woodland, MD 520 Mary St Ste 520, Evansville, IN 47710-1682 Ph: (812) 424-8231 |
News Archive
Patients with age-related macular degeneration or diabetic retinopathy who used a mobile application to test their vision at home got comparable results to in-office vision testing, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.
Scientists at the University of North Carolina at Chapel Hill have demonstrated that normal development of the eye requires the right amount of a neural stem cell gene be expressed at the right time and place.
The drug known as ecstasy has been used by 12 million people in the United States alone and millions more worldwide. Past research has suggested that ecstasy users perform worse than nonusers on some tests of mental ability. But there are concerns that the methods used to conduct that research were flawed, and the experiments overstated the cognitive differences between ecstasy users and nonusers.
BHR Pharma, LLC announced today the European Medicines Agency (EMA), responsible for evaluating medicines developed for use in the European Union, granted an orphan medicinal product designation for treating moderate and severe traumatic brain injury (TBI) to its proprietary intravenous progesterone infusion agent, BHR-100. The agent currently is being evaluated as a neuroprotective treatment for severe traumatic brain injury (TBI) in the global, Phase III SyNAPSe® clinical trial.
Thirty-five countries now face serious food shortages, including two dozen in Africa, according to a report released by the United Nations Food and Agricultural Organization (FAO).
› Verified 3 days ago
Dawn M Burgess, RNFA Surgery Medicare: Not Enrolled in Medicare Practice Location: 2701 Lincoln Ave, Evansville, IN 47714 Phone: 812-476-4400 Fax: 812-476-0300 | |
Dr. Santi Vibul, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 520 Mary St, Suite 520, Evansville, IN 47710 Phone: 812-424-8231 Fax: 812-435-8782 | |
Dr. Samir K. Gupta, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Mary St Ste 520, Evansville, IN 47710 Phone: 812-424-8231 Fax: 812-435-8794 | |
Dr. Anthony David Kaiser, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Mary St Ste 520, Evansville, IN 47710 Phone: 812-424-8231 Fax: 812-435-8794 | |
Dr. Brian W Schymik, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Mary St Ste 520, Evansville, IN 47710 Phone: 812-424-8231 Fax: 812-435-8794 | |
Dr. Prasad V Gade, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Mary St Ste 520, Evansville, IN 47710 Phone: 812-424-8231 Fax: 812-435-8794 | |
Dr. Katherine Mckenna Kottwitz, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 111 S Green River Rd Ste F, Evansville, IN 47715 Phone: 812-436-1203 |